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ABSTRACT
A prevalence of 3.47% of asymptomatic Chlamydia trachomatis urethritis has been 
previously reported among males living with HIV infection in Brazil. This study aims to 
assess the recurrence of C. trachomatis urethritis three years later in the same cohort of 
patients and analyze associated risk factors. A total of 115 male patients diagnosed with 
HIV infection, with no symptoms of urethritis and observed since May of 2015 in follow-
up visits were enrolled. They had urine samplers tested by PCR for C. trachomatis and N. 
gonorrhoeae between February and March 2018. Results: Three of the four patients who 
had asymptomatic C. trachomatis urethritis three years before were recurrently positive 
for C. trachomatis urethritis. Two new patients were diagnosed as positives, accounting 
for a total asymptomatic C. trachomatis urethritis prevalence of 4.34%. The prevalence 
during the whole study was 5.21%. The relative risk for a new urethritis episode among 
those previously diagnosed with urethritis is RR=41.62 (95% CI: 9.42-183.84), p < 0.01. 
Patients who presented asymptomatic urethritis anytime and who were recurrently positive 
for C. trachomatis had a lower mean age (p<0.01). Married individuals were protected 
regarding asymptomatic urethritis [p<0.01, OR = 0.04 (0.005-0.4)] and had lower risk to 
develop recurrence [p<0.01, RR = 0.86 (0.74-0.99)]. Illicit drugs users had risk associated to 
asymptomatic urethritis [p=0.02, OR= 5.9 (1.03-34)] and higher risk to develop recurrence 
[p<0.01, RR=1.1 (1-1.22)]. Conclusion: The recurrence of asymptomatic C. trachomatis 
urethritis after treatment among males living with HIV infection in Brazil can be considered 
high and should not be neglected. 
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INTRODUCTION
A prevalence of 3.47% has been previously reported for asymptomatic urethritis 
among males living with HIV infection, treated in a large reference center for HIV 
infection in Brazil. All cases were caused by Chlamydia trachomatis1. These data 
were compared with studies in the general population without HIV infection, which 
report a prevalence of asymptomatic urethritis of 5% in military Brazilian men and 
also with other similar studies in the United States that presented prevalences of 
1.5%, 3.7% and 5.7%2-5. Studies on asymptomatic urethritis specifically in male 
populations living with HIV are scarce, but the prevalences reported were 3.8%, 
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6% and 8%, all infections with Chlamydia trachomatis 
involvement6-8. C. trachomatis infection is the most 
prevalent sexually transmitted infection (STI) worldwide1. 
Considering that a large percentage of C. trachomatis 
infections are asymptomatic, many countries have 
established public health strategies for infection screening 
and control9,10. 
Taking into consideration that the majority of studies 
were performed in symptomatic healthy women rather than 
in asymptomatic males with HIV, as we propose, persistent 
or recurrent urethritis due to chlamydial infection was 
reported in 13% of those assigned to standard partner 
referral treatment and 11% of those assigned to expedited 
treatment of sexual partners11. A two- to three-fold 
increased risk of chlamydial persistence or recurrence 
was observed among younger (=24 years old) and white 
women reporting any of the following: a recent new 
partner, multiple partners, a partner who may have had 
multiple partners, or that not all partners were treated 
during the 1-month follow-up period after the initiation 
of treatment12,13. Another study indicated that reinfection 
was not clearly associated with having a new sex partner 
or other sexual behavior risks; new infection was likely 
due to the resumption of sex with untreated partners. 
Overall, 13.4% of women had persistent infections or 
became reinfected after a median of 4.3 months, a rate of 
33 infections per 1,000 person-month14.
In a systematic review of chlamydial and gonococcal 
urethritis reinfection among men, recurrent chlamydia 
infection had a median of reinfection probability of 11.3%. 
Recurrent gonorrhea infection among men had a median 
of reinfection probability of 7.0%. Studies with active 
follow-up each 3-6 months had moderate rates of chlamydia 
and gonorrhea reinfection among men, with respective 
median rates of 10.9% and 7.0%. Studies with passive 
follow-up varying from 30 days to 4.8 years had higher 
proportions of both chlamydia and gonorrhea reinfections 
among men, with respective medians of 17.4% and 8.5%. 
Proportions of chlamydia and gonorrhea reinfection 
among men were comparable with those among women. 
Reinfection among men was strongly associated with 
a previous history of sexually transmitted diseases and 
younger age and was inconsistently associated with risky 
sexual behavior. Retesting recommendations in men are 
appropriate given the high rate of reinfection15.
This study aims to assess the recurrence of 
C. trachomatis urethritis three years after treatment in the 
same studied cohort and analyze the associated risk factors. 
To our knowledge, there are no other studies that evaluated 
this situation in patients living with HIV.
MATERIALS AND METHODS
Patient recruitment
In this prospective study, a total of 115 male patients were 
enrolled, including only those who were diagnosed with HIV 
infection and had no symptoms of urethritis or other STIs, 
aged 18 years or older, visiting the Immunology Outpatient 
Clinic of the Gaffree and Guinle University Hospital between 
May and August 2015. In the previous study in 20151, we 
selected 111 patients (111/115) negative for asymptomatic 
urethritis and four patients (4/115) with asymptomatic 
urethritis due to C. trachomatis (prevalence = 3.47%) who 
were treated together with their respective partners, and all 
of the subjects tested negative for urethritis one week later. 
We tested the 115 patients again three years later (February 
and March of 2018), searching for new prevalence data, 
recurrence or new cases of asymptomatic urethritis. All 
positive patients and their partners were treated or retreated 
with an oral, single dose of azithromycin (1 gram).
Collection of demographic and clinical data
This clinical and epidemiological study consisted of 
data collection from medical records and interview with the 
researcher responsible for data collection regarding: age, 
date of birth, place of residence, date of the first attendance, 
date of the first anti-HIV-1 positive test , ART treatment (yes 
or no), marital status, schooling (in years), sexual habits (sex 
with men and/ or women), sexual intercourse with multiple 
partners (≥ 3 per year) use of antibiotic prophylaxis against 
pneumocystosis, neurotoxoplasmosis and Mycobacterium 
avium complex infections according to the CD4+ count, 
frequency of condom use, alcoholism (defined as the regular 
use of alcoholic beverages in quantities sufficient to cause 
significant social, interpersonal, family and/ or organic 
problems) and use of illicit drugs.
Specimen collection and laboratory testing
Urine samples were collected and tested by real-time 
PCR for the detection of C. trachomatis and N. gonorrhoeae 
(Abbott RealTime CT/NG test®). Simultaneous blood 
collection was performed to obtain HIV viral load values 
(detection level of 40 copies/mL) and CD4+T lymphocyte 
counts.
Data analysis and statistical calculations
The descriptive data analysis was performed by 
calculating the mean and standard deviation for continuous 
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variables and the frequency of categorical variables. 
Associations between variables and the presence of 
asymptomatic urethritis, risks between variables and the 
development of recurrent asymptomatic urethritis were 
assessed by the chi-square test. Associations between 
categorical and continuous variables were assessed by 
analysis of variance followed by comparison of means by the 
Student t-test. A multivariate logistic regression analysis was 
performed using as covariables those that were statistically 
significant, binaries and categoricals, in order to identify 
variables independently associated with the diagnosis. Odds 
ratio (OR) was used as a measure of association between an 
exposure and an outcome in the transversal analysis. Relative 
risk (RR) was used as a measure of risk or protection between 
an exposed in comparison to a non-exposed group in the 
prospective analysis. The level of statistical significance was 
set to 5%. The programs SPSS® 17.0 and Epi Info 7® were 
used for analyses.
Ethics
The study was evaluated and approved by the ethics 
committee of the University Hospital Gaffree and Guinle, 
under the Nº 02366912.1.0000.5248. All patients signed 
the informed consent forms, and the study followed all 
the guidelines for experimental investigation and ethical 
standards with human subjects required by the institution 
and the Helsinki Declaration.
RESULTS
Patient recruitment and demographics
The mean age of patients was 47.43 years, and 
the mean time of HIV diagnosis was 13.28 years. All 
(100%) patients were using ART, and 15 patients (13%) 
were under prophylaxis for opportunistic infections 
with trimethoprim/sulfamethoxazole alone (8 patients; 
7%) or associated with macrolide (7 patients; 6%). The 
mean CD4+T lymphocyte count for the subjects was 
488 cells/mm3, and 86% of patients had undetectable 
plasma HIV viral loads. Regarding lifestyle habits, 62% of 
the patients reported sexual practices with men, 72% had 
multiple partners (≥ 3 per year) and 55% used condoms in 
sexual intercourse approximately 50% of the time. 
Prevalence of urethritis
Three of the four patients (75%) who had asymptomatic 
C. trachomatis urethritis in the previous study and were 
treated together with their partners in 2015 were recurrently 
positive for C. trachomatis urethritis. Two new patients were 
diagnosed as positive, accounting for a total C. trachomatis 
urethritis prevalence of 4.34% (five patients). Again, there 
were no cases of N. gonorrhoeae infection. The descriptions 
of cases are in Table 1. The total number of asymptomatic 
urethritis cases detected during the study was six patients, 
with a prevalence of 5.21%. Those who have previously 
had C. trachomatis asymptomatic urethritis presented 
forty-one times greater risk of developing a new urethritis 
episode three years later compared to those who did not 
have previous C. trachomatis asymptomatic urethritis 
(RR=41.62; 95% CI: 9.42-183.84; p < 0.01).
Risk factors
Patients who presented with asymptomatic urethritis 
at any time and who were recurrently positive for 
C. trachomatis had a lower mean age (p<0.01).
We found associations with marital status, with married 
men having less risk of asymptomatic urethritis [p<0.01, 
OR = 0.04 (0.005-0.4)], and with the use of illicit drugs 
increasing the risk for asymptomatic urethritis [p=0.02, 
OR= 5.9 (1.03-34)].
Married men had 14% less risk of developing recurrent 
asymptomatic urethritis [p<0.01, RR = 0.86 (0.74-0.99)], 
and the use of ilicit drugs increased the risk of developing 
recurrent asymptomatic urethritis by 10% [p<0.01, RR=1.1 
Table 1 - Epidemiological data of the cases of asymptomatic urethritis detected during the study (with and without recurrence).
Case Previous CT 
urethritis
CT urethritis 
detected Age Schooling MSM CD4/Viral Load
Marital 
status Diagnostic Drug use
1 yes yes 28 < 10yr - 212/detected Single 6yr yes
2 yes yes 26 ≥10yr + 178/detected Single 6yr yes
3 yes yes 43 <10yr + 572/undetected Single 7yr yes
4 yes no 41 ≥10 yr - 450/undetected Married 11yr no
5 no yes 28 ≥10 yr + 141/undetected Single 5yr yes
6 no yes 33 <10yr + 506/undetected Single 5yr no
CT:Chlamydia trachomatis, MSM – male who have sex with men
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(1.0-1.22)]. The descriptive analysis and associations 
between the group with and without urethritis and the risk 
analysis of recurrent urethritis are in Table 2.
To estimate adjusted OR and RR for factors associated 
with the presence of asymptomatic urethritis in the 
univariate analysis, a multivariate logistic regression 
analysis was performed. A model was created to include 
marital status and use of illicit drugs. The presence of 
asymptomatic urethritis was independently associated 
with marital status [p<0.01, OR = 0.1 (0.01-0.3)], [p<0.01, 
RR=0.9 (0.8-0.99)] and use of illicit drugs [p<0.05, OR=4.2 
(1.2-27)], [p<0.01, RR=1.2 (1.0-1.3)].
DISCUSSION
A prevalence of 3.47% of asymptomatic urethritis 
has been previously reported in this studied sample, all 
cases caused by C. trachomatis, and three years later, the 
prevalence is 4.34%. These data can be compared with 
studies in males living with HIV, as well as studies in the 
general population without HIV infection and other similar 
studies in different countries2-8.
The present study shows that a proportion of male 
patients living with HIV who have previously had 
asymptomatic urethritis and were treated for this condition, 
including their respective partners, have recurrence of 
infection three years later. All of them tested negative after 
the first antibiotic regimen against C. trachomatis three 
years earlier. We found recurrence among three of the four 
patients who had been previously infected (75%). Recurrent 
symptomatic urethritis caused by chlamydia infection is 
reported at a prevalence of 13%11, 5.1%12 and 4.1%13 among 
non-HIV-infected women and 11.3% among men15. There 
are no data on the recurrence of asymptomatic urethritis in 
males or females or among HIV patients.
Explanations for the high rate of recurrence in our study 
may be related to the follow-up period of three years, which 
is a long period of time to test recurrence when compared 
to the period of months investigated in previous studies of 
symptomatic urethritis15. Retesting of all chlamydia- and 
gonorrhea-infected men and women three months after 
the initial treatment is recommended by some groups15. 
Positive retesting for Chlamydia infection is more common 
among men who have sex with men (MSM) than among 
Table 2 - Descriptive analysis and associations between the group with and without urethritis and risk analysis of recurrent urethritis 
(N = 115).
Variables Total (N = 115)
No Urethritis 
(N = 109)
Recurrent 
Urethritis 
(N = 3)
Urethritis 
Anytime 
(N = 6)
Associations with 
Urethritis at anytime
Risks of recurrent 
Urethritis
P value OR (CI95) P value RR (CI95)
Age (years) 47.43 ± 10.6 48.22 ± 10.2 32.33 ± 9.2 33.16 ± 7.2 <0.01* - <0.01* -
Marital status
Single 25/115 (22%) 20/109 (18%) 3/3 (100%) 5/6(83%) <0.01* 0.04 <0.01* 0.86
Married 90/115 (78%) 89/109 (82%) 0/3 (0%) 1/6(27%) (0.005-0.4) (0.74-0.99)
Schooling < 10 yrs 32/115 (28%) 29/109 (27%) 2/3 (66%) 3/6 (50%) 0.13 0.36 0.1 0.94
> 10 yrs 83/115 (72%) 80/109 (73%) 1/3 (34%) 3/6 (50%) (0.07-1.9) (0.86-1.04)
Time diagnosis 
(yrs) 13.28 ± 7.4 13.42 ± 7.2 6.33 ± 5.7 10.67 ± 10.2 0.37 - 0.1
Prophylaxis No 100/115 (87%) 96/109 (24%) 2/3 (66%) 4/6 (66%) 0.1 3.7 0.2 1.05
Yes 15/115 (13%) 13/109 (76%) 1/3 (34%) 2/6 (34%) (0.6-22.2) (0.9–1.2)
Sexual behavior 
(MSM)
No 44/115 (38%) 42/109 (39%) 1/3 (34%) 2/6 (34%) 0.41 1.25 0.4 1.0
Yes 71/115 (62%) 67/109 (61%) 2/3 (66%) 4/6 (66%) (0.22-7.1) (0.94-1.06)
Multiple Partners No 31/115 (27%) 30/109 (28%) 1/3 (34%) 1/6 (17%) 0.31 1.9 0.4 0.99
Yes 84/115 (73%) 79/109 (72%) 2/3 (66%) 5/6 (83%) (0.21-17) (0.92-1.06)
Condom <50% 52/115 (45%) 49/109 (45%) 2/3 (66%) 3/6 (50%) 0.40 0.81 0.2 0.97
≥50% 63/115 (55%) 60/109 (55%) 1/3 (34%) 3/6 (50%) (0.15-4) (0.91-1.04)
Alcoholism
No 104/115 (90%) 100/109 (92%) 2/3 (66%) 4/6 (%) 0.05 5.55 0.1 1.08
Yes 11/115 (10%) 9/109 (8%) 1/3 (34%) 2/6 (%) (0.9-34.6) (0.88-1.34)
Illicit drug use No 84/115 (73%) 89/109 (82%) 0/3 (0%) 2/6 (34%) 0.02* 5.9 <0.01* 1.1
Yes 31/115 (27%) 30/109 (18%) 3/3 (100%) 4/6 (66%) (1.03-34) (1.0-1.22)
CD4+ (cells/mm³) 488 ± 309 492 ± 315 320 ± 218 413 ± 175 0.54 0.34
Viral load
≤40/mL 99/115 (86%) 85/109 (78%) 2/3 (66%) 4/6 (66%) 0.26 1.77 0.32 1.01
>40/mL 16/115 (14%) 24/109 (22%) 1/3 (34%) 2/6 (34%) (0.3-10) (0.93-1.1)
Asymptomatic 
urethritis - 94,8% 2,6%
5,21% 
(4,34%)**
SD – standard deviation. *(p<0.05).** Prevalence in this study.
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heterosexuals and treatment failure is more common in 
MSM15. Other possible reasons are as follows: the focus 
on studying asymptomatic cases; the population profile 
(MSM living with HIV, most of them with multiple partners, 
using condoms in sexual intercourse less than 50% of the 
time). These risk factors were analyzed but results were not 
statistically significant. However, the absence of evidence 
does not mean evidence of absence, and a larger sample 
size could influence these results. Other studies suggest that 
reinfection among men can be related to a previous history 
of sexually transmitted diseases as well as younger age and 
is associated with risky sexual behavior15. Because all of the 
recurrence cases tested negative after their first treatment 
three years ago, the new infections were likely to be due to 
resumption of sex with untreated partners.
In our sample, patients who presented with asymptomatic 
urethritis at any time and who were recurrently positive for 
C. trachomatis had a lower mean age, consistent with the 
literature already presented12,13,15. The age factor may be 
related to a greater frequency of sexual intercourse or 
exposure to multiple partners. Similarly, less exposure to 
multiple partners can also explain the protective effect of 
marriage with respect to the prevalence of asymptomatic 
urethritis and the development of recurrent asymptomatic 
urethritis. The use of illicit drugs increasing the risk for 
asymptomatic urethritis and the development of recurrent 
asymptomatic urethritis can be explained by negligent 
behavior (e.g., sexual intercourse with multiple partners 
or negligent condom use) and even by non-trustworthy 
reporting or memory bias in sexual behavior questions. 
This study has limitations related to the small sample 
size combined with the small prevalence of asymptomatic 
urethritis. On the other hand, a prospective evaluation 
including treatment of positive patients and partners and 
sequential retesting (after treatment and three years later) 
can contribute to the understanding of the natural history of 
the development and recurrence of asymptomatic urethritis 
and risk factors associated with this condition. This study 
argues for retesting.
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